Folgen
Bahaa G. M. Youssif
Bahaa G. M. Youssif
Bestätigte E-Mail-Adresse bei pharm.aun.edu.eg
Titel
Zitiert von
Zitiert von
Jahr
2-Nitroimidazole-Tricarbocyanine Conjugate as a Near-Infrared Fluorescent Probe for in Vivo Imaging of Tumor Hypoxia
K Okuda, Y Okabe, T Kadonosono, T Ueno, BGM Youssif, ...
Bioconjugate chemistry 23 (3), 324-329, 2012
1732012
Synthesis, anticancer activity and molecular modeling studies of 1, 2, 4-triazole derivatives as EGFR inhibitors
HAM El-Sherief, BGM Youssif, SNA Bukhari, AH Abdelazeem, ...
European journal of medicinal chemistry 156, 774-789, 2018
1612018
Novel 1, 2, 4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies
HAM El-Sherief, BGM Youssif, SNA Bukhari, M Abdel-Aziz, ...
Bioorganic chemistry 76, 314-325, 2018
1402018
EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules
HA Abou-Zied, BGM Youssif, MFA Mohamed, AM Hayallah, M Abdel-Aziz
Bioorganic chemistry 89, 102997, 2019
1152019
Globally approved EGFR inhibitors: Insights into their syntheses, target kinases, biological activities, receptor interactions, and metabolism
MAS Abourehab, AM Alqahtani, BGM Youssif, AM Gouda
Molecules 26 (21), 6677, 2021
972021
Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents
M Hisham, BGM Youssif, EEA Osman, AM Hayallah, M Abdel-Aziz
European Journal of Medicinal Chemistry 176, 117-128, 2019
742019
Design and synthesis of novel quinoline/chalcone/1, 2, 4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
AM Mohassab, HA Hassan, D Abdelhamid, AM Gouda, BGM Youssif, ...
Bioorganic chemistry 106, 104510, 2021
662021
Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino [1, 2-a] indol-1 (2H)-ones as potential anticancer …
BGM Youssif, MH Abdelrahman, AH Abdelazeem, HM Ibrahim, OIA Salem, ...
European Journal of Medicinal Chemistry 146, 260-273, 2018
662018
Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance
GF Zha, HL Qin, BGM Youssif, MW Amjad, MAG Raja, AH Abdelazeem, ...
European Journal of Medicinal Chemistry 135, 34-48, 2017
642017
Linseed hydrogel-mediated green synthesis of silver nanoparticles for antimicrobial and wound-dressing applications
MT Haseeb, MA Hussain, K Abbas, BGM Youssif, S Bashir, SH Yuk, ...
International journal of nanomedicine, 2845-2855, 2017
622017
Design and synthesis of novel 2, 3-dihydropyrazino [1, 2-a] indole-1, 4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors
LH Al-Wahaibi, AM Gouda, OF Abou-Ghadir, OIA Salem, AT Ali, ...
Bioorganic Chemistry 104, 104260, 2020
522020
Novel pyrrol-2 (3H)-ones and pyridazin-3 (2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors
MS Abdelbaset, GEDA Abuo-Rahma, MH Abdelrahman, M Ramadan, ...
Bioorganic chemistry 80, 151-163, 2018
522018
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
FAM Mohamed, HAM Gomaa, OM Hendawy, AT Ali, HS Farghaly, ...
Bioorganic Chemistry 112, 104960, 2021
502021
Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory …
MH Abdelrahman, BGM Youssif, AH Abdelazeem, HM Ibrahim, ...
European Journal of Medicinal Chemistry 127, 972-985, 2017
492017
Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors
MAI Elbastawesy, AA Aly, M Ramadan, YAMM Elshaier, BGM Youssif, ...
Bioorganic chemistry 90, 103045, 2019
482019
5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents
BGM Youssif, AM Mohamed, EEA Osman, OF Abou-Ghadir, DH Elnaggar, ...
European Journal of Medicinal Chemistry 177, 1-11, 2019
462019
Novel aryl carboximidamide and 3-aryl-1, 2, 4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies
BGM Youssif, MFA Mohamed, MM Al-Sanea, AH Moustafa, ...
Bioorganic chemistry 85, 577-584, 2019
462019
Synthesis and mechanistic studies of curcumin analog‐based oximes as potential anticancer agents
HL Qin, J Leng, BGM Youssif, MW Amjad, MAG Raja, MA Hussain, ...
Chemical biology & drug design 90 (3), 443-449, 2017
452017
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1, 3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac …
SA Abdel-Aziz, ES Taher, P Lan, GF Asaad, HAM Gomaa, NA El-Koussi, ...
Bioorganic Chemistry 111, 104890, 2021
442021
Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities
AH Abdelazeem, MT El-Saadi, EG Said, BGM Youssif, HA Omar, ...
Bioorganic Chemistry 75, 127-138, 2017
442017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20